Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 11, 301-303, May 1, 1951]
© 1951 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Riegel, B.
Right arrow Articles by Stanger, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Riegel, B.
Right arrow Articles by Stanger, D. W.

Delay of Methylcholanthrene Skin Carcinogenesis in Mice by 1,2,5,6-Dibenzofluorene* ,{dagger}

Byron Riegel, William B. Wartman, Willard T. Hill, Blanchard B. Reeb, Philippe Shubik{ddagger} and D. Warren Stanger

( Departments of Chemistry and Pathology, Northwestern University, Evanston and Chicago, Illinois)

1. The addition of 1,2,5,6-dibenzofluorene to methylcholanthrene delays skin carcinogenesis in mice.
2. Chrysene, fluorene, and 1,2,7,8-dibenzofluorene have no delaying effect on methylcholanthrene skin carcinogenesis in mice.

* A preliminary report of this work was given at the meeting of the American Association for Cancer Research, Inc., Atlantic City, April, 1950, and at the Fifth International Cancer Congress, Paris, July, 1950.

{dagger} This investigation was supported by a research grant from the National Cancer Institute of the National Institutes of Health, Public Health Service.

{ddagger} Present address: Chicago Medical School, 710 South Wolcott Avenue, Chicago 8, Ill.

Received 8/ 4/50.


This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
B. Yu, B. M. Dietz, T. Dunlap, I. Kastrati, D. D. Lantvit, C. R. Overk, P. Yao, Z. Qin, J. L. Bolton, and G. R.J. Thatcher
Structural modulation of reactivity/activity in design of improved benzothiophene selective estrogen receptor modulators: induction of chemopreventive mechanisms
Mol. Cancer Ther., September 1, 2007; 6(9): 2418 - 2428.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1951 by the American Association for Cancer Research.